Tonix Pharmaceuticals Holding Corp (TNXP)
EBITDA Growth
-43.70%
Quarterly · Period ending:
TNXP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-43.70%period ending
Latest reported-43.70%period ending
TNXP Quarterly EBITDA YoY % (-20.11% → -43.70%)
Year-over-year change
High-resolution chart · PNG
TNXP ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -43.7007% | |
| -142.6481% | |
| -114.7973% | |
| -130.2342% | |
| 64.176% | |
| -18.989% | |
| 17.0715% | |
| 48.7911% | |
| -182.7447% | |
| 57.2465% | |
| 15.5071% | |
| 6.8572% | |
| -19.0859% | |
| -21.8487% | |
| -4.4639% | |
| -55.1409% | |
| 2.1575% | |
| -27.1298% | |
| -73.519% | |
| -54.4325% | |
| -65.9805% | |
| -184.3231% | |
| -94.9364% | |
| -52.0543% | |
| -140.4814% | |
| -15.951% | |
| -14.2689% | |
| -42.6556% | |
| 3.7369% | |
| 9.8236% | |
| -38.3125% | |
| 5.0009% | |
| -28.6314% | |
| -37.6159% | |
| 25.7562% | |
| 23.1815% | |
| 51.5164% | |
| 63.6956% | |
| 44.1977% | |
| 42.7654% | |
| 16.4527% | |
| -44.2733% | |
| -48.4025% | |
| -78.1772% | |
| -94.5897% | |
| -87.2991% | |
| -142.5216% | |
| -140.544% | |
| -190.2978% | |
| -158.638% | |
| -193,568.4432% | |
| -78.4697% | |
| -12.7126% | |
| -79.7499% | |
| 99.9432% | |
| -70.9526% | |
| -422.5702% | |
| -117.2279% | |
| -57,839.3809% | |
| -27,366.2687% | |
| -14,616.0283% | |
| -8,684.5929% | |
| -67.0017% | |
| -41.0256% | |
| 82.7294% | |
| 46.4102% | |
| -10.6099% | |
| 28.4502% | |
| -162.9609% | |
| -20.1106% |